Thursday, June 27, 2024

Google Alert - finance

Google
finance
As-it-happens update ⋅ June 27, 2024
NEWS
PRNewswire
As anticipated, eosinophil depletion occurred rapidly within 4 weeks after the start of benralizumab treatment, and almost 90% of the patients had a histologic response after 24 weeks. Unfortunately, clinical symptoms of dysphagia did not ...
Facebook Twitter Flag as irrelevant
www.nejm.org
Although second-line CD19-targeted chimeric antigen receptor (CAR) T-cell therapy for persistent or early relapsing disease has improved outcomes, most patients with relapsed or refractory disease still ultimately succumb to lymphoma.
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)